Company: SVREW
Filing Date: 2025-01-31
Form Type: 424B5
Source: 0001213900-25-008656
Chunk: 38

Company: SaverOne 2014 Ltd.
Filing Date: 2025-01-31
Form: 424B5
Chunk 38
---
 prospectus supplement to the extent that a statement contained
herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies
or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this prospectus supplement and accompanying prospectus. The information we incorporate by reference is an important
part of this prospectus supplement and the accompanying prospectus, and later information that we file with the SEC will automatically
update and supersede the information contained in this prospectus supplement and accompanying prospectus.

We will provide you without
charge, upon your written or oral request, with a copy of any of the documents incorporated by reference in this prospectus, other than
exhibits to such documents which are not specifically incorporated by reference into such documents. Please direct your written or telephone
requests to us at: SaverOne 2014 Ltd., Em Hamoshavot Rd. 94, Petah Tikva, 4970602, Israel, Attention: Chief Financial Officer, Tel.:
+972-3909-4177.

<div align='center'>S-25

PROSPECTUS

SaverOne 2014 Ltd.

$50,000,000

Ordinary Shares

American Depositary Shares Representing Ordinary Shares

Subscription Rights

Warrants
Units</div>

We may offer, issue and sell
from time to time up to US $50,000,000 of our ordinary shares, including in the form of American Depositary Shares, or ADSs, warrants
to purchase ordinary shares, including in the form of ADSs, subscription rights and a combination of such securities, separately or as
units, in one or more offerings.

Each ADS represents 5 ordinary
shares. This prospectus provides a general description of offerings of these securities that we may undertake.

We refer to the ADSs, ordinary
shares, subscription rights, warrants and units, collectively, as the “securities” in this prospectus. We may offer, issue
and sell the securities at an aggregate public offering price that will not exceed $50,000,000.

Each time we sell securities
pursuant to this prospectus, we will provide in a supplement to this prospectus the price and any other material terms of any such offering.
Any prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and